250 GENES FOUNDi
Show / hide columns XML | RDF | TSV | « prev | Page of 5 | next »
Genei Gene descriptioni x Protein classi x Tissue Cell Pathology Subcellular locationi x RNA tissue categoryi x
KCNC3Potassium voltage-gated channel subfamily C member 3Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCND2Potassium voltage-gated channel subfamily D member 2Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCND3Potassium voltage-gated channel subfamily D member 3Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNH2Potassium voltage-gated channel subfamily H member 2Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNJ1Potassium voltage-gated channel subfamily J member 1Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
KCNJ12Potassium voltage-gated channel subfamily J member 12FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Nucleoplasm
Golgi apparatus
Cytosol
Group enriched
KCNJ8Potassium voltage-gated channel subfamily J member 8Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNK2Potassium two pore domain channel subfamily K member 2FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
KCNK3Potassium two pore domain channel subfamily K member 3Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNK9Potassium two pore domain channel subfamily K member 9Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Group enriched
KCNN4Potassium calcium-activated channel subfamily N member 4Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNQ1Potassium voltage-gated channel subfamily Q member 1Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNQ2Potassium voltage-gated channel subfamily Q member 2Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Endoplasmic reticulumTissue enriched
KCNQ3Potassium voltage-gated channel subfamily Q member 3Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
KITKIT proto-oncogene receptor tyrosine kinaseCancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
RAS pathway related proteins
Plasma membraneTissue enhanced
LEPRLeptin receptorCancer-related genes
Candidate cardiovascular disease genes
CD markers
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
VesiclesMixed
LHCGRLuteinizing hormone/choriogonadotropin receptorDisease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
MC2RMelanocortin 2 receptorDisease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Tissue enriched
MS4A1Membrane spanning 4-domains A1CD markers
Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Plasma membraneGroup enriched
MS4A2Membrane spanning 4-domains A2FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Tissue enhanced
MTNR1AMelatonin receptor 1AFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Tissue enhanced
MTNR1BMelatonin receptor 1BFDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
NPC1L1NPC1 like intracellular cholesterol transporter 1FDA approved drug targets
Predicted membrane proteins
Tissue enhanced
NTSR2Neurotensin receptor 2FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enriched
OPRD1Opioid receptor delta 1FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
OPRK1Opioid receptor kappa 1FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Nucleus
Plasma membrane
Cytosol
Group enriched
OPRM1Opioid receptor mu 1FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Tissue enhanced
OXTROxytocin receptorFDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Tissue enriched
P2RX4Purinergic receptor P2X 4FDA approved drug targets
Predicted membrane proteins
Transporters
Actin filaments
Cytosol
Mixed
P2RY12Purinergic receptor P2Y12Disease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enriched
P2RY2Purinergic receptor P2Y2FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
CytosolTissue enhanced
PDE3APhosphodiesterase 3ADisease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
CytosolMixed
PTGER1Prostaglandin E receptor 1FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Tissue enhanced
PTGER2Prostaglandin E receptor 2FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Mixed
PTGER3Prostaglandin E receptor 3FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Group enriched
PTGER4Prostaglandin E receptor 4FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Expressed in all
PTGFRProstaglandin F receptorFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
PTGIRProstaglandin I2 (prostacyclin) receptor (IP)FDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
PTH2RParathyroid hormone 2 receptorFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Mixed
RYR1Ryanodine receptor 1Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Golgi apparatus
Vesicles
Cytosol
Tissue enriched
RYR2Ryanodine receptor 2Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Nucleoplasm
Plasma membrane
Cytosol
Tissue enriched
S1PR1Sphingosine-1-phosphate receptor 1Cancer-related genes
CD markers
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
VesiclesExpressed in all
S1PR5Sphingosine-1-phosphate receptor 5FDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
SCN10ASodium voltage-gated channel alpha subunit 10Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Voltage-gated ion channels
Not detected
SCN11ASodium voltage-gated channel alpha subunit 11Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
SCN1ASodium voltage-gated channel alpha subunit 1Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Nucleoplasm
Nuclear bodies
Plasma membrane
Group enriched
SCN2ASodium voltage-gated channel alpha subunit 2Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
SCN3ASodium voltage-gated channel alpha subunit 3FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
SCN4ASodium voltage-gated channel alpha subunit 4Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Nucleoplasm
Microtubule organizing center
Group enriched
SCN5ASodium voltage-gated channel alpha subunit 5Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
« prev | Page of 5 | next »